Can GLP-1 drugs for obesity and diabetes, like Ozempic and Wegovy, help change the food industry? Consumers on these drugs experience a decline in their appetite and their appeal for sugary snacks filled with fats and sodium. Could this inspire consumer products companies to create healthier snacks?
Can GLP-1 drugs for obesity and diabetes, like Ozempic and Wegovy, help change the food industry? Consumers on these drugs experience a decline in their appetite and their appeal for sugary snacks filled with fats and sodium. Could this inspire consumer products companies to create healthier snacks?
The increasing adoption of wearable devices is expected to drive the growth of the global health and wellness market. The primary factor behind this growth.
Initial reaction from the launch of Oreo Zero sugar-free cookies in China has been disappointing, Mondelez International Inc's CEO said, underscoring some of the challenges facing the global snack giant as it makes a big push in the market.